NuVista Energy Ltd. (TSX:NVA)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,818	2,837	2,320	2,799	1,584	212
Market Cap Growth	11.29%	22.28%	-17.11%	76.75%	646.39%	-70.50%
Enterprise Value	3,097	3,159	2,617	3,145	2,195	949
Last Close Price	14.30	13.82	11.04	12.48	6.96	0.94
PE Ratio	7.77	9.28	6.31	4.44	5.98	-
Forward PE	7.47	8.93	5.76	4.47	8.38	-
PS Ratio	2.45	2.62	1.84	1.81	1.93	0.52
PB Ratio	1.16	1.21	1.10	1.45	1.10	0.18
P/TBV Ratio	1.16	1.21	1.10	1.45	1.10	0.18
P/FCF Ratio	12.77	28.46	14.49	6.58	31.85	-
P/OCF Ratio	4.11	4.73	3.22	3.31	4.68	1.44
EV/Sales Ratio	2.70	2.91	2.07	2.03	2.68	2.33
EV/EBITDA Ratio	3.71	4.37	3.48	2.97	5.99	6.46
EV/EBIT Ratio	5.82	7.29	5.20	3.69	11.04	-
EV/FCF Ratio	14.04	31.69	16.34	7.39	44.14	-
Debt / Equity Ratio	0.12	0.12	0.14	0.17	0.38	0.61
Debt / EBITDA Ratio	0.34	0.39	0.40	0.31	1.44	4.58
Debt / FCF Ratio	1.28	2.89	1.91	0.78	10.88	-
Asset Turnover	0.34	0.33	0.43	0.59	0.36	0.18
Quick Ratio	0.47	0.55	0.73	0.97	0.44	0.54
Current Ratio	0.92	1.00	1.04	1.31	0.44	0.54
Return on Equity (ROE)	16.74%	13.68%	18.15%	37.44%	20.42%	-15.79%
Return on Assets (ROA)	9.92%	8.33%	10.71%	20.44%	5.46%	-0.58%
Return on Capital (ROIC)	12.83%	10.71%	13.43%	25.10%	6.47%	-0.68%
Return on Capital Employed (ROCE)	16.20%	13.50%	17.60%	32.70%	9.10%	-
Earnings Yield	13.56%	10.78%	15.85%	22.54%	16.71%	-93.26%
FCF Yield	7.83%	3.51%	6.90%	15.20%	3.14%	-15.67%
Buyback Yield / Dilution	4.93%	6.05%	5.82%	-1.31%	-3.26%	-0.11%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.